Trial Profile
Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms RESET
- 09 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Mar 2014 Optical coherence tomography results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
- 29 Aug 2011 1 year clinical outcomes were presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.